Archive · 17 Dec 2025
Park Medi World and Nephrocare Health IPO Listings
Park Medi World and Nephrocare Health, two healthcare companies in India, recently launched their initial public offerings (IPOs).
Park Medi World's IPO was open from December 10 to December 12 and listed on December 17.
The price band was ₹154-162 per share, and the IPO was subscribed 8.52 times.
The grey market premium (GMP) was ₹5.5, suggesting a listing price of around ₹167.5.
However, the actual listing price was ₹158 on NSE and ₹155.60 on BSE, which was a discount of 2.5% and 3.95% respectively.
Nephrocare Health's IPO had a price band of ₹438-460 per share and was subscribed 13.96 times.
The GMP for Nephrocare Health was ₹37, indicating a potential listing price of ₹470-480.
The actual listing price was ₹490 on NSE and ₹491 on BSE, which was a premium of 6.89%.
Both companies plan to use the funds raised for expanding their healthcare services, repaying debt, and general corporate purposes.
The IPOs received strong interest from investors, particularly in the institutional and retail segments.
Park Medi World IPO listed on December 17 with a price band of ₹154-162 per share and a subscription of 8.52 times.
Nephrocare Health IPO listed on December 17 with a price band of ₹438-460 per share and a subscription of 13.96 times.
Park Medi World's GMP was ₹5.5, suggesting a listing price of around ₹167.5, but it listed at a discount of 2.5% on NSE and 3.95% on BSE.
Nephrocare Health's GMP was ₹37, indicating a potential listing price of ₹470-480, and it listed at a premium of 6.89% on both NSE and BSE.
Both companies plan to use the funds raised for expanding healthcare services, repaying debt, and general corporate purposes.
- Who
- Park Medi World and Nephrocare Health, healthcare providers in India
- What
- Initial public offerings (IPOs) and their listings on the Indian stock market
- When
- Park Medi World IPO listed on December 17, Nephrocare Health IPO listed on December 17
- Where
- India (BSE and NSE)
- Why
- To raise funds for acquisitions, capital expenditure, debt reduction, and general corporate purposes
- Park Medi World IPO Launch Date
- December 10
- Park Medi World IPO Closing Date
- December 12
- Park Medi World IPO Listing Date
- December 17
- Park Medi World IPO Price Band
- ₹154-162 per share
- Park Medi World IPO Issue Size
- ₹920 crore
- Park Medi World IPO Subscription
- 8.52 times
- Park Medi World IPO GMP
- ₹5.5
- Park Medi World IPO Expected Listing Price
- ₹167.5
- Park Medi World IPO Actual Listing Price (NSE)
- ₹158
- Park Medi World IPO Actual Listing Price (BSE)
- ₹155.60
- Park Medi World IPO Listing Discount (NSE)
- 2.5%
- Park Medi World IPO Listing Discount (BSE)
- 3.95%
- Nephrocare Health IPO Launch Date
- December 10
- Nephrocare Health IPO Closing Date
- December 12
- Nephrocare Health IPO Listing Date
- December 17
- Nephrocare Health IPO Price Band
- ₹438-460 per share
- Nephrocare Health IPO Issue Size
- ₹871 crore
- Nephrocare Health IPO Subscription
- 13.96 times
- Nephrocare Health IPO GMP
- ₹37
- Nephrocare Health IPO Expected Listing Price
- ₹470-480
- Nephrocare Health IPO Actual Listing Price (NSE)
- ₹490
- Nephrocare Health IPO Actual Listing Price (BSE)
- ₹491
- Nephrocare Health IPO Listing Premium (NSE)
- 6.89%
- Nephrocare Health IPO Listing Premium (BSE)
- 6.89%
Sources
Gujarat Kidney & Super Speciality IPO: From date, price band to GMP - here's all you need to know about upcoming IPO
KSH International IPO off to a slow start, subscribed 15% on first day; GMP remains nil
Nephrocare Health IPO listing date today — GMP experts signal positive debut of shares on Dalal Street
Park Medi World IPO listing date today. Here's what GMP, experts signal
Nephrocare, Park Medi World: Two IPO listings today; check latest GMP before D st listing
Nephrocare Health IPO listing LIVE: GMP signals positive debut, 8% listing gains on Indian stock market
KSH International IPO Day 2: Issue subscribed 15% so far. Check GMP, subscription status, other details - apply or not?
Park Medi World shares disappoint on market debut; stock lists at 4% discount
Nephrocare Health IPO listing: Shares make modest debut, list at 6.9% premium
Park Medi World debuts lower on NSE, share price lists at ₹158, down 2.5% from IPO price
